Healthcare -
Biotechnology - NASDAQ - US
$ 422.0
1.21 %
$ 109 B
Market Cap
-219.79
P/E
VRTX - CASH FROM OPERATIONS
Cash from Operations VRTX - Vertex Pharmaceuticals Incorporated
3.54 B
LAST VALUE
15.68%
2 YEAR CAGR
22.73%
5 YEAR CAGR
53.06%
10 YEAR CAGR